Volume 13, Issue 1, Pages 1-2 (January 2008)

Slides:



Advertisements
Similar presentations
What We Talk About When We Talk About Fat Evan D. Rosen, Bruce M. Spiegelman Cell Volume 156, Issue 1, Pages (January 2014) DOI: /j.cell
Advertisements

Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages (October 2013) DOI: /j.ccr
ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics Carlos L. Arteaga, Jeffrey A. Engelman Cancer Cell Volume.
Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia Tim C.P. Somervaille, Michael L. Cleary Cancer Cell.
Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53- independent and mTORC1-dependent manner Jennifer E. Skeen, Prashanth.
Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm Thierry Soussi, Klas G. Wiman Cancer Cell Volume 12, Issue 4, Pages (October.
Inflammation and Cancer: IL-6 and STAT3 Complete the Link
The Kinase-Independent, Second Life of CDK6 in Transcription
We Contain Multitudes: The Protean Face of Retinoblastoma
Unraveling the TWIST between EMT and Cancer Stemness
“Atypical” Regulation of Hedgehog-Dependent Cancers
Connecting COX-2 and Wnt in cancer
Metastasis gets site specific
Accelerating drug discovery: Open source cancer cell biology?
PI3K Regulatory Subunits Lose Control in Cancer
A Time to Divide: Does the Circadian Clock Control Cell Cycle?
Volume 14, Issue 2, Pages (August 2008)
A Flt3L Encounter: mTOR Signaling in Dendritic Cells
DAISY: Picking Synthetic Lethals from Cancer Genomes
Volume 26, Issue 1, Pages 1-2 (July 2014)
T.S. Karin Eisinger-Mathason, M. Celeste Simon  Cancer Cell 
Suppressing NFAT Increases VEGF Signaling in Hemangiomas
The Wind God Promotes Lung Cancer
A Radical Role for p38 MAPK in Tumor Initiation
MicroRNA Regulation of Stem Cell Fate
Foxo1 and Foxo3 help Foxp3 Immunity
PTEN Enters the Nuclear Age
Apoptosis-targeted therapies for cancer
The p27Kip1 tumor suppressor gene: Still a suspect or proven guilty?
Volume 22, Issue 6, Pages (December 2012)
Raf-1 and Squamous Cell Carcinoma: Rok-ing the Boat
Taru Muranen, Funda Meric-Bernstam, Gordon B. Mills  Cancer Cell 
Volume 20, Issue 1, Pages 3-5 (July 2011)
The great MYC escape in tumorigenesis
Characterizing the Killer Colorectal Carcinomas
PARP Inhibitors in Cancer Therapy: Promise, Progress, and Puzzles
Inflammation Joins the “Niche”
Global Edgetic Rewiring in Cancer Networks
Cellular Signal Processing: Out of One, Many
Andrew J. Holland, Don W. Cleveland  Cancer Cell 
PARP Inhibitors in Cancer Therapy: Promise, Progress, and Puzzles
NOTCH and PI3K-AKT Pathways Intertwined
Hard Times for Oncogenic BRAF-Expressing Melanoma Cells
BMPing Off Glioma Stem Cells
Apoptosis-targeted therapies for cancer
John D. Gordan, Craig B. Thompson, M. Celeste Simon  Cancer Cell 
Autocrine IL-6 Signaling: A Key Event in Tumorigenesis?
Alex Kentsis, A. Thomas Look  Cell Stem Cell 
Genome-Wide SNP Analysis in Cancer: Leukemia Shows the Way
Mst Out and HCC In Cancer Cell
A common pathway for genetic events leading to pheochromocytoma
Khalid S. Mohammad, Theresa A. Guise  Cancer Cell 
To Infinium, and Beyond! Cancer Cell
Volume 10, Issue 3, Pages (September 2006)
All Roads Lead to the Ribosome
Co-opted integrin signaling in ErbB2-induced mammary tumor progression
Volume 25, Issue 2, Pages (January 2007)
Glycogen Synthase Kinase-3 and Cancer: Good Cop, Bad Cop?
There's a Time and a Place for MYCN
Is Cyclin D1-CDK4 kinase a bona fide cancer target?
Tipping the Energy Balance toward Longevity
Gankyrin: An intriguing name for a novel regulator of p53 and RB
PTENtiating CFTR for Antimicrobial Immunity
New Myc-anisms for DNA Replication and Tumorigenesis?
Mind the IQGAP Cancer Cell
Volume 12, Issue 6, Pages (December 2007)
Anthony N. Imbalzano, Stephen N. Jones  Cancer Cell 
Turning Reciprocal Feedback Regulation into Combination Therapy
Skp2, the FoxO1 hunter Cancer Cell
Presentation transcript:

Volume 13, Issue 1, Pages 1-2 (January 2008) Live or Let Die: E2F1 and PI3K Pathways Intersect to Make Life or Death Decisions  Brian David Dynlacht  Cancer Cell  Volume 13, Issue 1, Pages 1-2 (January 2008) DOI: 10.1016/j.ccr.2007.12.017 Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 1 The Fateful Intersection of E2F1 and PI3K Pathways in Normal and Cancer Cells Growth factors stimulate proliferation through two branches involving distinct CDK- and PI3K-Akt kinase pathways that simultaneously liberate E2F1 activity while suppressing apoptosis. Normal growth is characterized by an E2F1-mediated balancing act that promotes expression of cell-cycle genes and apoptosis to eliminate cells with deregulated E2F-1 activity. Hyperactivity or mutations in the PI3K pathway could abnormally suppress the apoptotic arm, promoting inappropriate proliferation and tumorigenesis. Cancer Cell 2008 13, 1-2DOI: (10.1016/j.ccr.2007.12.017) Copyright © 2008 Elsevier Inc. Terms and Conditions